United States News All stories

ADARx Pharmaceuticals announced plans to pursue a U.S. initial public offering that could value the rare disease-focused biotechnology company at up to approximately $1.74 billion.

Titan International (NYSE:TWI) announced a definitive agreement to sell its Italtractor ITM undercarriage business to USCO S.p.A. for cash consideration linked to closing adjustments and future performance.

Advanced Micro Devices (NASDAQ:AMD) briefly surpassed a $1 trillion market capitalization on Monday as investors continued to bet on the company’s expanding role in artificial intelligence infrastructure.

Paramount Skydance (NASDAQ:PSKY) has reportedly reached a settlement with California and other states that challenged its proposed $110 billion merger with Warner Bros. Discovery, according to Bloomberg News.

Tiziana Life Sciences (NASDAQ:TLSA) announced that the final patient has completed the final visit in its Phase 2a INFORM-MS clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS).

Sunrun (NASDAQ:RUN) and Tesla (NASDAQ:TSLA) announced that more than 140,000 residential batteries supplied over 580 megawatts of peak power to California’s electricity grid during an extreme heat event on September 9, 2026.

CAE (NYSE:CAE) announced that it has been awarded a competitive recompete contract valued at approximately $300 million by the U.S. Air Force to continue providing C-130H aircrew training services through December 2035.

NewAmsterdam Pharma (NASDAQ:NAMS) and partner Menarini Group announced that the European Commission has granted marketing authorization for Ubeslo® (10 mg obicetrapib monotherapy) and Evlarco® (10 mg obicetrapib plus 10 mg ezetimibe).

Microchip Technology (NASDAQ:MCHP) announced the completion of its acquisition of Hailo Technologies, a provider of accelerated edge AI processors, vision processors, robotics processors and AI software technologies.

Anixa Biosciences (NASDAQ:ANIX) announced that it received its first Australian composition-of-matter patent for its breast cancer vaccine technology.

BlackLine (NASDAQ:BL) announced the acquisition of NetNow, an AI-enabled B2B customer onboarding and credit risk management platform designed to improve financial operations.

National CineMedia (NASDAQ:NCMI) announced the completion of its previously announced acquisition of Captivate Holdings for an enterprise value of $275 million.

Nuvini Group (NASDAQ:NVNI) reported improved financial performance for the first half of 2026, with operating income reaching R$19.6 million compared with an operating loss of R$32.0 million in the same period last year.

Johnson & Johnson (NYSE:JNJ) announced positive topline results from a pivotal Phase 3 trial evaluating CAPLYTA® (lumateperone) 42 mg once daily for the treatment of acute manic episodes in adults with bipolar I disorder.

JPMorgan's (NYSE:JPM) asset management division and Qatar Investment Authority have signed a Memorandum of Understanding for a strategic investment partnership valued at $20 billion.

ZJK Industrial (NASDAQ:ZJK) reported first-half 2026 financial results, with revenue reaching US$33.74 million for the six months ended June 30, 2026, representing a 36.6% increase compared with the prior-year period.

AbbVie (NYSE:ABBV) announced a multi-year collaboration with Iambic Therapeutics to apply artificial intelligence technologies to discover and develop small molecule therapies.

Magnachip Semiconductor (NYSE:MX) announced that Navitas Semiconductor (NASDAQ:NVTS) will make a $5 million strategic equity investment in the company.

Syntec Optics Holdings (NASDAQ:OPTX) announced an order to supply advanced optical components for U.S. Space Force infrastructure and U.S. National Reconnaissance Office satellite constellations.

Helus Pharma (NASDAQ:HELP) presented four posters on its investigational oral deuterated psilocin analog HLP003 for major depressive disorder (MDD) at Psych Congress 2026 in New Orleans.

Priority Technology Holdings (NASDAQ:PRTH) entered a definitive agreement to be acquired by an investor group led by Chairman and CEO Thomas Priore, which will purchase all outstanding shares it does not already own for $8.05 per share in cash.

Bruker (NASDAQ:BRKR) announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation valued at more than $6 million.

Alkermes (NASDAQ:ALKS) reported positive topline results from a phase 1 proof-of-concept study evaluating ALKS 7290, an investigational orexin 2 receptor agonist being developed for attention-deficit hyperactivity disorder (ADHD).

Kodiak Gas Services (NYSE:KGS) entered an agreement to provide 76 megawatts of behind-the-meter baseload power capacity, including balance of plant services, to a West Texas data center for six years.